Presented at the 45th annual San Antonio Breast Cancer Symposium® (2022 SABCS®), primary results of the multicenter international POSITIVE study…
en_news
Presented today (1) at the 45th annual San Antonio Breast Cancer Symposium® (2022 SABCS®), results of the phase II SERENA-2…
Recently published in Nature Reviews Gastroenterology & Hepatology*, a comprehensive Review focused on gastric cancer and gastro-oesophageal junction cancer (GC-GOJC)…
Results of a study led by María Abad, Principal Investigator of VHIO’s Cellular Plasticity and Cancer Group, identify a new…
Published today, Clarivate has revealed its annual #HighlyCited2022 researchers list. Featuring among the world’s elite scientists at academic research institutes and…
Co-authored by Ana Vivancos, Principal Investigator of VHIO’s Cancer Genomics Group, and VHIO’s Director Josep Tabernero, a News & Views…
The oncology channel ecancer recently launched a new series of videos focused on Genomics in Oncology. Leading experts are invited…
Preliminary results from a phase I clinical trial show that the first in class MYC inhibitor Omomyc (OMO-103) has few…
This is shown in the results of the CheckMate 915 study, in which Dr. Eva Muñoz-Couselo, investigator in the Breast…
Now published in ESMO Perspectives digital magazine, the latest edition of On Target – Artificial Intelligence: a ‘smart’ arrow in our quiver against cancer –…
